Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, April 1, 2022
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
Thu, March 31, 2022
[ Thu, Mar 31st 2022
] - WOPRAI
[ Thu, Mar 31st 2022
] - WOPRAI
Do Kim Initiated (TVTX) at Buy and Held Target at $42 on, Mar 31st, 2022
Do Kim of Piper Sandler, Initiated "Travere Therapeutics, Inc." (TVTX) at Buy and Held Target at $42 on, Mar 31st, 2022.
Do has made no other calls on TVTX in the last 4 months.
There are 3 other peers that have a rating on TVTX. Out of the 3 peers that are also analyzing TVTX, 0 agree with Do's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Do
- Ed Arce of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $45 on, Monday, February 28th, 2022
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $42 on, Thursday, December 16th, 2021
- Carter Gould of "Barclays" Maintained at Buy with Increased Target to $40 on, Thursday, December 16th, 2021
